Regorafenib Enhances Radiation-inhibited Tumor Growth by Inducing Apoptosis in Colorectal Cancer
碩士 === 中臺科技大學 === 醫學影像暨放射科學系暨研究所 === 107 === The study goal is to investigate therapeutic efficacy and mechanism of reografenib combined with radiation in colorectal cancer (CRC) in vivo. CRC CT-26 tumor mice were established and used for study. Mice were treated with reografenib, radiation, or comb...
Main Authors: | HUANG, I-CHI, 黃乙奇 |
---|---|
Other Authors: | LIN, SONG-SHEI |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/xmmwus |
Similar Items
-
The use of regorafenib in colorectal cancer
by: Marina I Sekacheva, et al.
Published: (2019-06-01) -
Regorafenib Enhances Lethality of Sildenafil and Curcumin in Colorectal Cancer Cells
by: Owusu, Kervin Benjamin
Published: (2019) -
The role of regorafenib in the treatment of metastatic colorectal cancer
by: A A Tryakin
Published: (2016-06-01) -
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
by: Dennis Doleschel, et al.
Published: (2021-09-01) -
Practical considerations in the use of regorafenib in metastatic colorectal cancer
by: Fotios Loupakis, et al.
Published: (2020-10-01)